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Abstract 
 
The term perinatal death is used to describe antepartum and intrapartum stillbirths, and 
early neonatal deaths. Although the overall rate of perinatal mortality is falling, a slower 
rate of reduction has been observed in stillbirth compared to neonatal death. Antenatal 
stillbirth contributes to a greater proportion of cases in high income countries and 
associated risk factors include maternal age, smoking, obesity and small for gestational age 
fetus. At term, intrapartum stillbirth and neonatal death are collectively referred to as 
delivery related perinatal death, and the incidence in nulliparous and multiparous women 
is approximately 1 in 1000 and 1 in 2000 births, respectively. Associated factors include 
advanced maternal age, small for gestational age, fetal macrosomia, breech labour and 
previous caesarean delivery. The impact of obstetric interventions in labour on delivery 
related perinatal death, including rising rates of caesarean delivery, is complex and unclear.  
 
Key words: Perinatal mortality, antepartum stillbirth, intrapartum stillbirth, early 
neonatal death, term births 
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Definition of Perinatal Death 
The World Health Organization (WHO) defines a perinatal death as ‘A death occurring at 
22 completed weeks of gestation and over, during childbirth and up to seven completed 
days of life’. This includes stillbirth (intrauterine fetal death) and early neonatal death 
(infant death occurring in the first 7 days of life). However, WHO also recommends a 
different definition for international comparison (≥1000g birthweight or ≥28 completed 
weeks of gestation). This “international” definition exists for two main reasons: firstly 
because national registries use different gestational age thresholds to define stillbirth; and 
secondly due to the under-reporting of stillbirths below 28 weeks in selected regions. It is 
recognised that the “international” definition for comparisons underestimate the real 
burden of perinatal mortality as a considerable proportion of fetal deaths occur before 28 
weeks of gestation (35-50% in high income countries). In the United Kingdom, 24 
completed weeks is used as the lower gestational limit to define a perinatal death (Table 
1). Gestations at the limit of viability can pose difficult problems for classification of events 
with respect to the incidence of late miscarriage or early neonatal death. A CMACE report 
has indicated that 7.3% of early neonatal deaths in London were born at less than 22 weeks, 
whereas this figure is 18.8% in the West Midlands. This highlights the lack of consistency 
in defining type of death across the country. Global comparisons are challenging as there 
are inter-country, and indeed intra-country variations in definitions, data collection, 
neonatal care at the gestational age of viability, timing of death, and even legal 
requirements to report death. International comparisons can be further complicated by 
changes of definitions over time.  
 
A Global perspective 
An estimated 98% of all perinatal deaths occur in countries of low income and the perinatal 
mortality rate is roughly five times greater than that of wealthier countries. This figure 
emphasises low income countries should be the focus of improvement programmes to 
reduce the burden of perinatal mortality globally. Although the overall rate of perinatal 
mortality is falling, a slower rate of reduction has been observed in stillbirth compared to 
neonatal death. This enhanced reduction in neonatal death is likely to be related to the 
Millennium Development Goal 4, which aims to reduce the under-five mortality rate. 
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Between 1990 and 2015 the under-five mortality rate declined by more than half, 
highlighting that targeting specific health outcomes can promote change. Stillbirth was not 
a specific target of the Millenium Development Goals, but recently the WHO launched the 
Every Newborn Action Plan (2014) which enhances and supports coordinated, 
comprehensive planning and implementation of newborn-specific actions with the specific 
goal of ending preventable stillbirth and neonatal death. Reduction in perinatal deaths 
requires financial, cultural and political will to implement universal access to good quality 
care in pregnancy, childbirth and the neonatal period. However, the strategy should vary 
according to local epidemiology. In low income countries intrapartum death is a major 
component of perinatal mortality, reaching over 50% of stillbirth in specific areas (Table 
2). Training health care providers to ensure appropriate management of deliveries and 
providing pregnant women with access to health care facilities are recognised measures 
that reduce intrapartum stillbirth. The remaining 2% of global perinatal deaths, which occur 
in countries of high income, are associated with different risk factors and causes, therefore 
different interventions are required to further improve outcomes (Table 3).  In high income 
countries, intrapartum stillbirths account at most for 15% of all stillbirths (0.5-1.2 per 1000 
births). A variation in the overall stillbirth rates is also observed between high income 
countries. If all countries had a low rate (2.0 per 1000 birth), approximately 20,000 late 
gestation stillbirths would be avoided. It is not clear the reason for those differences 
observed in high income countries, neither the best way to tackle antenatal stillbirth. In the 
UK, the stillbirth rate has fallen in the last decade from 5.7/1,000 livebirths in 2004 to 
4.7/1,000 livebirth in 2014 (Figure 1). Some of the strategies being suggested to further 
improve this rate involve smoking cessation, increasing maternal awareness of reduced 
fetal movements and improved screening and follow up of small for gestational age fetus 
(SGA). The focus of the rest of this review is on the incidence and causes of perinatal 
mortality in high income countries. 
 
Classification 
There are over 30 classification systems of perinatal mortality. Many of these classification 
systems were designed for different reasons with different definitions and levels of 
complexity. In the UK in the 1950s, a classification system was developed to group 
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perinatal death according to the obstetric cause. The aim of this system was to identify the 
factor which initiated the chain of events leading to death, hence the system was 
hierarchical. For example, it was assumed that a lethal fetal malformation would take 
precedence over any other cause of death. With time it became clear from national surveys 
of perinatal deaths that there was a need to further develop classification of cases to 
incorporate changes in obstetric practices such as the significantly improved prognosis of 
very low birth weight babies. Classification systems incorporating the use of specific 
diagnoses such as those listed in the International Classification of Disease (ICD) have also 
been used. However, many specific diagnoses relating to perinatal death are missing from 
even the most recent ICD classification.  
 
Each of the different systems has its merits, however, a systematic approach to the 
classification of perinatal death is required to improve the understanding and prevention of 
perinatal death. In addition, it is recognised that the contribution from each cause of death 
will be different for antenatal, intrapartum and neonatal death. Moreover, approximately 
50% of stillbirth (antenatal and intrapartum deaths) were unexplained according to 
different cause–related classification systems. A more recent classification system takes 
into account the relevant condition at death (ReCoDe) and reduces the number of deaths 
previously classified as unexplained to 15% (Figure 2). The major difference of this system 
is to acknowledge conditions associated with death instead of reporting only causative 
disorders. Although causal relationship is not proven, the prevalence of associated 
conditions helps to inform where interventions are more likely to impact on the rate of 
stillbirth. It is of note that fetal growth restriction, not accounted for in previous 
classifications, is present in approximately 40% of stillbirths. Irrespective of the 
classification, the cause of death should ideally be decided by a medically qualified 
assessor with access to all the relevant data, including clinical records and the results of 
postmortem investigations. 
 
Antepartum Stillbirth 
Approximately two thirds of all perinatal deaths are stillbirths occurring in the antenatal 
period and there has been considerable research focused on risk prediction of this event. 
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Tackling antenatal stillbirth is especially important to reduce stillbirth in high income 
countries, where intrapartum causes are responsible for only 8-10% of cases. These fetuses 
die in-utero prior to the onset of labour and associations include fetal abnormality, maternal 
diseases, congenital infections, isoimmunisation and complications of pregnancy such as 
placental abruption, gestational diabetes mellitus and pre-eclampsia. However, for many 
antepartum stillbirths, no specific cause is found, and these are referred to as unexplained. 
A large proportion of these unexplained deaths are associated with SGA/intrauterine 
growth restriction. Epidemiological risk factors for antepartum stillbirth include advanced 
maternal age, nulliparity, smoking, low socio-economic status, obesity, advanced 
gestational age, previous stillbirth, and multiple pregnancies. From all factors associated 
with antepartum stillbirth the major contributors, according to population attributable 
fraction, are maternal age, smoking, obesity and SGA. The most prevalent single condition 
associated with stillbirth is SGA, thus appropriate definition, detection and management of 
SGA fetuses is an important strategy to reduce the rate of stillbirths.  
 
There are two methods commonly used to define an SGA fetus (ultrasound estimated fetal 
weight  below the 10th centile): population centiles, which adjust for gestational age and 
fetal sex; and customised centiles, which adjust for maternal height and weight, ethnicity, 
parity, gestational age and fetal sex. Evidence from observational studies support SGA 
infants by customised, but not by population centiles, are at increased risk for perinatal 
adverse outcomes (including stillbirth). SGA infants by population, but not by customised 
centiles, are not at increased risk. This would suggest that the use of customised centiles 
better predicts fetuses at risk. However, the customisation process does not account for 
potential pathological influences on fetal growth such as maternal obesity recognised as a 
pathological variation of weight, and ethnicity which in some groups is associated with 
socioeconomic deprivation. Recently the INTERGROWTH 21st project has published a 
new international standard of fetal growth in line with the WHO principles of child growth 
charts. Pooled data from 8 different countries was used to create a standard to compare 
populations. However, the validity for applying this reference to individual patients and 
the association with adverse perinatal outcomes has not been established. 
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The key issue in reducing stillbirth associated with SGA is to improve detection 
irrespective of the definition used locally. It is recognised that antenatal identification of 
SGA fetuses can reduce the risk of stillbirth through appropriate follow up with Doppler 
ultrasound and timely delivery. The Grow Assessment Protocol (GAP) is a complex 
intervention for improved detection of SGA infants, which includes risk stratification in 
early pregnancy, serial fundal height measurement or ultrasound scans during second and 
third trimester, and use of customised charts for assessment of fetal growth. Studies suggest 
that the use of GAP can double the detection of SGA (from 16-20% to 38-42%). Another 
strategy to improve antenatal detection of SGA is universal screening with third trimester 
ultrasound. A recent cohort study reported universal third trimester ultrasound provides a 
detection rate of 67% compared to 20% with routine care. Health economic analysis 
comparing these two strategies should inform the most effective way to improve detection 
of SGA. 
 
Maternal perception of reduced fetal movements is another established risk factor for 
stillbirth. The mechanism leading to death is not clear in this group but the related 
association with increased risk of growth restriction suggests placenta insufficiency may 
be involved. Induction of labour is recommended when repeated episodes of reduced fetal 
movement occur in term pregnancies, even if tests of fetal wellbeing are normal. It has 
been hypothesised that increasing awareness of reduced fetal movements could lead to 
earlier report of these episodes by pregnant women. Such early report of reduced fetal 
movements associated with clear management of these episodes has the potential to reduce 
rates of stillbirth. The AFFIRM trial is a stepped wedge trial which is testing this hypothesis 
and is due to complete in March 2017. Other strategies to reduce antepartum stillbirth 
include smoking cessation programmes, induction of labour for post-date pregnancies, and 
elective delivery of multiple pregnancies at or before 37 weeks’ gestation. 
Cardiotocography and biophysical profiling are tools that are routinely used but their 
benefit in preventing antepartum stillbirth remains unproven.    
 
Placental function is determined early in pregnancy and requires extensive uterine 
remodelling to accommodate deep trophoblast invasion. Markers of placentation have been 
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investigated and incorporated into clinical practice. Low levels of pregnancy-associated 
plasma protein A (PAPP-A) at 11-13 weeks (< 0.415 MoM) are associated with both SGA 
fetus and other adverse obstetric outcomes, therefore serial growth scans are indicated. An 
abnormal uterine artery Doppler measurement at 20-24 weeks’ gestation is defined as a 
pulsatility index (PI) above the 95th centile and/or notching. If this occurs in a high risk 
pregnancy, the Royal College of Obstetricians and Gynaecologists (RCOG) recommends 
serial ultrasound scans from 26-28 weeks’ gestation to assess fetal size and umbilical artery 
Doppler measurements. 
 
Intrapartum Stillbirth and Early Neonatal Death 
Overall, prematurity is the leading cause of intrapartum stillbirth and neonatal deaths and 
it is therefore difficult to disentangle the effect of prematurity from the effects of the care 
provided in labour. Studies from high income countries have reported more than a 50% 
reduction in delivery related perinatal deaths over the last four decades. In recent years, 
improvements in neonatal care have significantly improved the rates of survival in pre-
term infants. Therefore it is difficult to determine the relative contribution of changes in 
obstetric and neonatal care on the trend of perinatal mortality in analyses which include 
pre-term births. 
 
Term Delivery Related Perinatal Death 
At term, intrapartum stillbirth accounts for approximately 15% of all stillbirths. Most 
neonatal deaths in normally formed fetuses at term are due to intrapartum related events 
(intrapartum anoxia and mechanical causes). These deaths are collectively referred to as 
delivery related perinatal death at term, and the rate of these deaths can be used as a marker 
for the quality of intrapartum care. 
 
1. Studying delivery related perinatal death 
There are a number of factors that make the study of delivery related perinatal deaths 
problematic. Firstly, in high income countries, the incidence of term intrapartum stillbirth 
and neonatal death is rare, being only 1 in 1000 for primiparous, and 1 in 2000 for 
multiparous, women. Therefore, large numbers of women are required to study factors 
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determining these events. Secondly, detailed information is required on perinatal mortality 
in order to define the event, and exclude antepartum stillbirths.  
 
2. Epidemiology 
Even with a falling perinatal mortality rate in high income countries wide variations exist 
even within a nation. For example in England in 2013, Yorkshire and the Humber had the 
highest adjusted stillbirth rate (4.7 per 1,000 total births) and the East of England had the 
lowest (3.9 per 1,000 total births). Unfortunately, such data does not always distinguish the 
specific causes of perinatal mortality and in particular how these relate to labour. In a 
detailed population based analysis from Scotland of term singleton fetuses with cephalic 
presentation, the incidence of both intrapartum stillbirth and neonatal death declined 
between 1985 and 2004. This was wholly due to a reduction in the incidence of intrapartum 
anoxic related deaths. Changes in obstetric care may have resulted in a shift in the timing 
of perinatal mortality in relation to labour. A reduction in intrapartum stillbirth may be 
associated with an increased incidence of neonatal death. The decline observed in the 
Scottish study coincides with the observed rising rate of caesarean section, however it may 
also be attributed to other aspects of improved obstetric care such as better 
multidisciplinary education training and senior clinical supervision. The association 
between rates of cesarean delivery and neonatal mortality is known and a recent ecological 
study including data from 194 WHO member states suggested that rates up to 19% were 
associated with lower neonatal mortality, which is higher than the 15% previously 
recommended. 
 
3a. Risk factors for delivery related perinatal death – maternal characteristics 
In most high income countries there has been a marked shift in maternal demographics in 
the last few decades, including age, obesity and family size. Women are choosing to delay 
childbirth. The association of advanced maternal age and the incidence of adverse 
pregnancy outcomes such as miscarriage, pre-eclampsia, gestational diabetes and 
antepartum stillbirth have been well described. Increasing maternal age is also found to be 
associated with intrapartum complications, including dysfunctional labour and operative 
birth. The association between maternal age and the risk of delivery related perinatal death 
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is less clear, although there is now evidence that women aged 40 and above are at greater 
than two-fold increased risk of delivery related perinatal death at term. This excess is 
secondary to deaths due to intrapartum anoxia and was independent of parity. The 
biological basis of this association is unclear. There are two main hypotheses; firstly, older 
women may have abnormal placental function, thus increasing the risk of anoxic related 
events. Secondly, there is a linear increase in the risk of operative delivery with increasing 
maternal age. This may be attributed in part to a reduction in spontaneous contractility of 
myometrial muscle fibres as evidenced by in vitro studies. 
 
In high income countries, increasing obesity is a major public health issue and it is 
associated with adverse pregnancy outcomes, including gestational diabetes mellitus, pre-
eclampsia, fetal macrosomia, caesarean delivery and antepartum stillbirth. Compared to 
multiparous women, nulliparity carries an increased risk of most adverse obstetric 
outcomes, including stillbirth. This also extends to delivery related perinatal death at term, 
with a 56% increase in the risk in nulliparous women. A linear association between 
antepartum stillbirth and neonatal death and socioeconomic status has been identified. 
However, no such association has been found between delivery related perinatal death at 
term and other maternal characteristics such as smoking and sociodemographic 
characteristics. 
 
3b. Risk factors for delivery related perinatal death – Fetal characteristics 
SGA and intrauterine growth restriction are associated with intrapartum stillbirth and 
neonatal death at term. There is a greater than two-fold risk of intrapartum stillbirth and 
neonatal death in SGA infants. It is estimated that SGA contributes to 17% of delivery 
related perinatal death. Conversely, there has been mounting concern regarding the trend 
of increasing birthweight in high income countries. Term pregnancies with a birthweight 
greater than 4500g or the 97th percentile were associated with more than a two-fold risk of 
infant death secondary to asphyxia. Despite compromising a smaller proportion of delivery 
related perinatal death (Population Attributable Factor 2.8-3.5%), there is a potential for 
improvement in intrapartum complications related to delivery of overgrown fetus. A recent 
randomised controlled trial assessed the effect of early term induction of labour in women 
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with a suspected large for gestational age (LGA) infant (ultrasound estimated fetal weight 
above the 95th centile at 36-38 weeks). Induction of labour at 37-39 weeks reduced the risk 
of shoulder dystocia and associated neonatal morbidity (RR 0.32; 95%CI 0.15-0.71) 
without increasing caesarean section rates (RR 0.89; 95%CI 0.72-1.09). One remaining 
challenge is how to accurately identify fetal overgrowth before labour. Reports suggest that 
antenatal identification of LGA in routine clinical practice is 9.7-16.6% which is similarly 
poor to the figures described for SGA (16.4-26.4%). This highlights the importance of 
improved antenatal estimation of birthweight and identification of infants at the extremes 
of birthweight percentiles as a strategy to reduce delivery related perinatal death.  
 
Breech presentation is associated with a higher risk of labour related perinatal mortality 
and morbidity. The Term Breech Trial demonstrated a three-fold greater risk of perinatal 
morbidity and mortality associated with vaginal breech delivery compared to planned 
caesarean delivery. This resulted in an immediate shift in clinical practice with most 
advocating planned caesarean delivery for breech presentation. However the debate on the 
appropriate management of breech pregnancies has continued. It has been demonstrated 
that despite exclusion of deaths due to congenital abnormalities, not all perinatal deaths in 
the Term Breech Trial were due to breech labour and delivery.  However, in a cohort study 
between 1985 and 2004, the absolute risk of anoxic or mechanical death in infants delivered 
by vaginal breech delivery was 25.5 per 10,000 births. In multivariate analysis, this risk 
was five times the risk in infants delivered by caesarean delivery following the onset of 
labour. There were no events among infants delivered by planned caesarean delivery. This 
analysis provides more precise risk estimation associated with breech delivery and labour.  
 
It is well recognised that twin pregnancies are associated with an increase in the risk of all 
causes of perinatal mortality. Labour and delivery are however a time of significant risk to 
twin pregnancies and in particular to the second twin. One study of twin pregnancies 
beyond 24 weeks demonstrated an excess in the risk of delivery related perinatal mortality 
associated with the second twin, which was only observed in pregnancies beyond 36 weeks. 
At term the absolute risk of delivery related perinatal death in the second twin was 
approximately 1 in 270 for all causes, 1 in 350 for deaths due to intrapartum anoxia and 1 
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in 500 for mechanical causes of death. Birthweight discordance was associated with an 
increased risk of death in the second twin. Observational studies have suggested that 
planned caesarean section could reduce the risk of perinatal death of twins which made the 
case for a randomised controlled trial. The Twins Birth Study was designed to test this 
hypothesis and randomised 2804 women for a planned caesarean delivery or a planned 
vaginal birth. In twin pregnancies with the first twin in cephalic presentation, planned 
caesarean delivery did not decreased the risk of fetal or neonatal death or serious neonatal 
morbidity (RR 1.16; 95%CI 0.77 – 1.74, p=0.49). 
 
3c. Risk factors for delivery related perinatal death – Obstetric and service 
The increase in the rate of caesarean section is partly attributed to the decline in vaginal 
birth after caesarean delivery (VBAC). This is driven, in part, by the concern of uterine 
rupture and the consequent perinatal mortality and morbidity. A systematic review has 
reported an increased perinatal mortality associated with an attempt of VBAC (13/10,000 
births) compared to elective repeated caesarean section (5/10,000 birth). However, the 
absolute risk is very low and risks and benefits of VBAC should be discussed with all 
women. Previous uterine rupture and classical uterine scar are particular risk factors for 
subsequent uterine rupture and consideration should be given to avoid VBAC in these 
situations. A large scale population based cohort study from Scotland reported that delivery 
in an obstetric unit with less than 3000 births per year was a risk factor for perinatal death 
following uterine rupture. Additional factors identified include prostaglandin induction and 
no previous vaginal delivery.  
 
It has been suggested that there might be associations between perinatal mortality rates and 
both the time and day of delivery and the place of birth. Births in the evening and night 
time were associated with almost a two-fold risk of both intrapartum stillbirth and neonatal 
death, although some reports have failed to demonstrate this association. It has been 
suggested this could be related to the presence of senior obstetricians on the birth units 
during day time. However a recent study exploring this hypothesis has shown no difference 
perinatal morbidity, low Apgar score at 5 min and low cord pH in relation to the presence 
of senior obstetricians in the labour ward. Differences in access to emergency care such as 
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“crash” caesarean delivery, resuscitation facilities and service provision out of hours may 
be responsible for the difference in the incidence observed. Regarding the place of birth, a 
systematic review and meta-analysis of home versus hospital birth failed to show any 
difference in the incidence of perinatal mortality. However, the Birthplace study has 
identified that in term cephalic pregnancies, the incidence of perinatal mortality and 
morbidity was higher in nulliparous women delivering at home compared to those 
delivering in an obstetric unit (9.3 per 1000 compared to 5.3 per 1000). This was not the 
case for multiparous women. The overall safety of births at home, in midwifery units, free 
standing or alongside obstetric units compared to births in hospitals has been demonstrated. 
 
4. Prevention of delivery related perinatal death 
Much of the intrapartum interventions such as electronic fetal monitoring (EFM), fetal 
blood sampling and operative delivery are aimed at reducing the risk of perinatal mortality 
and morbidity associated with labour and delivery. EFM in labour is a screening test aimed 
at identifying infants at risk of asphyxia. The sensitivity, specificity and prevalence of the 
outcome influence the positive predictive value of the test. The outcome of interest is rare, 
and this screening test has a high false positive rate and poor predictive value. Continuous 
EFM versus intermittent auscultation is associated with an increase in the risk of obstetric 
intervention including caesarean delivery, with no difference in the incidence of perinatal 
mortality having been demonstrated. However, in order to test the hypothesis that 
continuous EFM can reduce the incidence of delivery related perinatal death a study would 
have to randomize more than 50,000 women in each arm. Therefore the absence of 
evidence is largely an issue of power and may not truly reflect a negative result. Currently, 
the use of EFM is only advocated in the presence of risk factors for intrapartum hypoxia. 
In those cases where EFM is indicated it has been suggested that the use of computer-based 
decision-support would earlier indicate the possibility of a poor outcome therefore 
improving outcomes through earlier intervention. The INFANT trial addresses this 
hypothesis and is due to report soon.  
 
The rate of caesarean delivery in most countries has increased significantly in the last 
twenty years and this has coincided with a decline in intrapartum stillbirth. The real effect 
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of mode of delivery on the risk of delivery related perinatal death associated with labour 
and delivery is not a question that can be studied easily. Firstly, it is not appropriate to 
randomize low risk women to caesarean section, therefore available evidence comes from 
observational studies. Secondly, the choice for a woman is not between planned caesarean 
delivery and vaginal birth but rather an attempt of vaginal birth and most studies have not 
taken that into account. This is an extension of the intention to treat principle. This approach 
was used in two large scale cohort studies on the risks of trial of labour in women with 
previous caesarean delivery. In both these studies, the risk of delivery related perinatal 
death associated with planned caesarean delivery at term was approximately 1 per 10,000. 
The additional risk associated with the decision of trial of vaginal delivery was 3 per 
10,000. This risk was comparable to the risk for women having their first birth. 
 
Conclusion 
 
Globally, although the rate of perinatal mortality is falling, a slower rate of reduction has 
been observed in stillbirth compared to neonatal death. Low and middle income countries 
contribute to the vast majority of perinatal deaths and there is a need for effective 
pregnancy, childbirth and postnatal care to reach all mothers and their babies in these 
nations.  
 
In the UK and in other high income countries, antenatal stillbirth is the major contributor 
to perinatal mortality. Risk factors for antenatal stillbirth have been identified such as 
advanced maternal age, smoking, obesity and SGA fetuses, but the clinical applicability of 
interventions has been limited. Ongoing studies may clarify which interventions are more 
cost-effective in reducing antenatal stillbirths. Despite the low incidence of delivery 
perinatal death in these countries, it remains a severe adverse obstetric outcome. 
Identification of risk factors and preventative strategies are limited by precise case 
ascertainment and issues of power. However, a number of risk factors for delivery related 
perinatal death have been identified, including multiple pregnancy, breech labour and 
previous caesarean delivery. Future research needs to target individual risk estimation, 
thereby directing intervention to women at high-risk of delivery related perinatal death. 
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Practice points 
 It is estimated that 98% of perinatal mortality occur in low income countries.  
 Antenatal stillbirth accounts for two thirds of perinatal mortality globally.  
 In the UK and in other high income countries, antenatal stillbirth represent at least 
85% of all stillbirths. 
 Risk factors for antenatal stillbirth include, but are not limited to, advanced 
maternal age, smoking, obesity and small for gestational age fetuses.  
 Maternal characteristics of risk factors for term delivery related perinatal death 
include advanced maternal age, obesity, nulliparity and low socioeconomic status. 
 Fetal characteristics of risk factors for term delivery related perinatal death include 
small for gestational age, intrauterine growth restriction, macrosomia (in diabetic 
mothers), breech presentation and multiple pregnancy. 
 Obstetric and service determinants of risk factors for term delivery related perinatal 
death include uterine rupture associated with vaginal birth after caesarean section, 
small obstetric units and place of birth. 
 In practice, prevention of term delivery related perinatal death depends largely on 
electronic fetal monitoring and caesarean section. However, these are likely to only 
be of benefit in situations where there is a high risk of intrapartum hypoxia.  
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Table 1. Summary of definitions related to perinatal mortality in UK. 
Stillbirth A baby delivered at or after 24
+0 weeks 
gestational age showing no signs of life, 
irrespective of when the death occurred. 
Antenatal Stillbirth A baby delivered at or after 24
+0 weeks 
gestational age showing no signs of life 
and known to have died before the onset 
of care in labour.  
Intrapartum stillbirth A baby delivered at or after 24
+0 weeks 
gestational age showing no signs of life 
and known to be alive at the onset of care 
in labour.  
Neonatal death A live born baby (born at 20
+0 weeks 
gestational age or later, or with a 
birthweight of 400g or more where an 
accurate estimate of gestation is not 
available) who died before 28 completed 
days after birth 
Early neonatal death A live born baby (born at 20
+0 weeks 
gestational age or later, or with a 
birthweight of 400g or more where an 
accurate estimate of gestation is not 
available) who died before 7 completed 
days after birth.  
Late neonatal death A live born baby (born at 20
+0 weeks 
gestational age or later, or with a 
birthweight of 400g or more where an 
accurate estimate of gestation is not 
available) who died from 7 completed 
days but before 28 completed days after 
birth. 
Perinatal mortality A stillbirth or early neonatal death. 
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Table 2. Global estimates stillbirth rates and proportion of intrapartum stillbirth according to region. Adapted from Lawn JE et al. Lancet 
2016 Jan;387(10018):587-603. 
 
Rate of all stillbirth 
(per 1,000 births) 
Number of 
stillbirths 
Number of 
intrapartum 
stillbirths 
Proportion of 
Intrapartum 
stillbirths 
Developed regions 3.4 (3.4-3.5) 46700 4700 10.0 (5.5-18.4) 
Eastern Asia 7.2 (5.6-9.7) 129000 25700 19.9 (6.6-32.3) * 
Latin America 8.2 (7.5-9.2) 91000 15300 16.8 (15.8-41.1) 
Caucasus and central Asia 11.9 (9.8-15.6) 23400 4700 19.9 (6.6-32.3) * 
Southeast Asia and Oceania 12.2 (10.7-14.6) 154900 70800 45.7 (31.3-74.5) 
Northern Africa and western Asia 14.5 (12.9-17.6) 148300 62300 42.0 (22.9-57.9) 
Southern Asia 25.5 (22.5-29.1) 966600 573200 59.3 (32.0-84.0) 
Sub-Saharan Africa 28.7 (25.1-34.2) 1059700 541500 51.1 (33.8-81.8) 
* Estimation of proportion of stillbirth calculated together. 
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Table 3. Commonly reported maternal risk factors and causes of stillbirth, reported by 
ranking of importance and developed status of the country Obtained from McClure EM et 
al. Int J Gynaecol Obstet 2006 Aug;94(2):82-90 
 
Developing Countries Developed Countries 
Obstructed/prolonged labour and 
associated asphyxia, infection and 
birth injury (low availability of 
caesarean section). 
Congenital / karyotypic anomalies 
Congenitally acquired infections 
especially syphilis and gram negative 
infections. 
Growth restriction / placental 
thromosis 
Hypertensive disease, especially poor 
management of pre-eclampsia and 
eclampsia. 
Medical disease such as diabetes, 
systemic lupus erythematosus, renal 
disease, thyroid disorders, 
thrombophilias, cholestatsis of 
pregnancy, hypertensive disease/pre-
eclampsia. 
Poor nutritional state Congenital acquired infections, 
especially group B Streptococcus and 
Parvovirus 19 
Previous stillbirth Smoking 
Congenital anomalies Multiple gestation  
Malaria  ------------------ 
Sickle cell disease ------------------ 
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Figure 1. Trend of stillbirth rates in UK between 2004 and 2014. 
 
Obtained from Office for National Statistics licensed under the Open Government Licence v.3.0. 
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Figure 2. Causes of stillbirth according to Wigglesworth (left) and ReCoDe (right) classifications. 
  
Obtained from Gardosi J, et al. Public Health. 2014;128(8):698-702. 
 
